These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26418020)

  • 1. 17β-Estradiol Attenuates Conduit Pulmonary Artery Mechanical Property Changes With Pulmonary Arterial Hypertension.
    Liu A; Tian L; Golob M; Eickhoff JC; Boston M; Chesler NC
    Hypertension; 2015 Nov; 66(5):1082-8. PubMed ID: 26418020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in large pulmonary arterial viscoelasticity in chronic pulmonary hypertension.
    Wang Z; Lakes RS; Golob M; Eickhoff JC; Chesler NC
    PLoS One; 2013; 8(11):e78569. PubMed ID: 24223157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen Preserves Pulsatile Pulmonary Arterial Hemodynamics in Pulmonary Arterial Hypertension.
    Liu A; Hacker T; Eickhoff JC; Chesler NC
    Ann Biomed Eng; 2017 Mar; 45(3):632-643. PubMed ID: 27557900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
    White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
    Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension.
    Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR
    Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced haemodynamic coupling and exercise are associated with vascular stiffening in pulmonary arterial hypertension.
    Bellofiore A; Dinges E; Naeije R; Mkrdichian H; Beussink-Nelson L; Bailey M; Cuttica MJ; Sweis R; Runo JR; Keevil JG; Francois CJ; Shah SJ; Chesler NC
    Heart; 2017 Mar; 103(6):421-427. PubMed ID: 27566296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.
    Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR
    Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.
    Lahm T; Frump AL; Albrecht ME; Fisher AJ; Cook TG; Jones TJ; Yakubov B; Whitson J; Fuchs RK; Liu A; Chesler NC; Brown MB
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L375-88. PubMed ID: 27288487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of estrogen on pulmonary arterial hypertension: role of oxidative stress.
    Siqueira R; Campos C; Colombo R; Becker CU; Fernandes TR; Araújo AS; Belló-Klein A
    Cell Biochem Funct; 2011 Oct; 29(7):543-8. PubMed ID: 21989892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up.
    Ploegstra MJ; Brokelman JGM; Roos-Hesselink JW; Douwes JM; van Osch-Gevers LM; Hoendermis ES; van den Bosch AE; Witsenburg M; Bartelds B; Hillege HL; Berger RMF
    Eur Heart J Cardiovasc Imaging; 2018 Feb; 19(2):216-224. PubMed ID: 28329155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
    Huh JW; Kim SY; Lee JH; Lee YS
    Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal pulmonary artery stiffness in pulmonary arterial hypertension: in vivo study with intravascular ultrasound.
    Lau EM; Iyer N; Ilsar R; Bailey BP; Adams MR; Celermajer DS
    PLoS One; 2012; 7(3):e33331. PubMed ID: 22479385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness.
    Stevens GR; Garcia-Alvarez A; Sahni S; Garcia MJ; Fuster V; Sanz J
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):378-87. PubMed ID: 22498327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.
    Frump AL; Albrecht M; Yakubov B; Breuils-Bonnet S; Nadeau V; Tremblay E; Potus F; Omura J; Cook T; Fisher A; Rodriguez B; Brown RD; Stenmark KR; Rubinstein CD; Krentz K; Tabima DM; Li R; Sun X; Chesler NC; Provencher S; Bonnet S; Lahm T
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.
    Kozu K; Sugimura K; Aoki T; Tatebe S; Yamamoto S; Yaoita N; Shimizu T; Nochioka K; Sato H; Konno R; Satoh K; Miyata S; Shimokawa H
    Heart Vessels; 2018 Aug; 33(8):939-947. PubMed ID: 29441403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.
    Schäfer M; Ivy DD; Nguyen K; Boncella K; Frank BS; Morgan GJ; Miller-Reed K; Truong U; Colvin K; Yeager ME
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H242-H252. PubMed ID: 34085841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved right ventricular-vascular coupling during active pulmonary hypertension.
    Grignola JC; Ginés F; Bia D; Armentano R
    Int J Cardiol; 2007 Feb; 115(2):171-82. PubMed ID: 16797089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.